Cardiac structural and hemodynamic changes following cancer therapy in patients with hypertrophic cardiomyopathy
Cardiotoxicity of cancer therapy is increasingly recognized as a critical determinant of long-term clinical outcome. However, evidence on cardiac structural and hemodynamic effects of oncological treatment in patients with hypertrophic cardiomyopathy (HCM) remains scarce. The aim of our study was to evalua...